SB-242235 is a potent and selective p38 MAP kinase inhibitor with IC50 of 1.0 uM.
Cat.No
DC7028
Name
SB242235
Chemical Properties
CAS
193746-75-7
Formula
C19H20FN5O
MW
353.39
Storage
References
[1]. Badger, A.M., et al., Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures. Osteoarthritis Cartilage, 2000. 8(6): p. 434-43.
[2]. Ward, K.W., et al., SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. I: preclinical pharmacokinetics. Xenobiotica, 2002. 32(3): p. 221-33.
[3]. Kim, A.L., et al., Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice. J Invest Dermatol, 2005. 124(6): p. 1318-25.
[4]. Ward, K.W., et al., SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. II: in vitro and in vivo metabolism studies and pharmacokinetic extrapolation to man. Xenobiotica, 2002. 32(3): p. 235-50.
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
